The LDL Uptake Assay Kit (Flow cytometry) (ab236208) employs human LDL conjugated to DyLightTM 488 as a convenient tool for studying the uptake of LDL in cultured cells.
Select an associated product type
The LDL Uptake Assay Kit (Flow cytometry) (ab236208) employs human LDL conjugated to DyLightTM 488 as a convenient tool for studying the uptake of LDL in cultured cells.
The LDL Uptake Assay Kit (Flow cytometry) (ab236208) employs human LDL conjugated to DyLightTM 488 as a convenient tool for studying the uptake of LDL in cultured cells. Flow cytometry provides the advantage of assessing the uptake of LDL at the single-cell level. In addition, multiplexing with other markers, such as LDLR expression, is possible to gain more information from a single experiment. The reagents provided in this kit are sufficient to test 48 samples by flow cytometry.
Low-density lipoprotein often referred to as LDL or "bad cholesterol" serves as a carrier for lipids in the bloodstream. LDL particles are spherical and contain an apolipoprotein B-100 shell with a core mostly filled with cholesterol esters. It has an approximate molecular weight of 2536 kDa. LDL is mainly expressed in the liver where it is released into the circulation to deliver cholesterol to various tissues. It is an essential component that transports cholesterol and other lipids through the body for structural and metabolic functions.
LDL plays an important role by supplying cholesterol to cells which is critical for membrane structure and hormone synthesis. LDL binds to specific receptors on the cell surface prompting its cellular uptake through the LDL uptake assay mechanisms including receptor-mediated endocytosis. This process involves the LDL protein engaging with a receptor complex facilitating the internalization of cholesterol for cell usage or storage. Native LDL can be distinguished from oxidized forms which have different roles in health and disease.
LDL is vital in cholesterol homeostasis and lipid metabolism pathways. One notable pathway includes its interaction in the mevalonate pathway essential for cholesterol biosynthesis. The interaction with the insulin signaling pathway also highlights the significance of LDL in energy homeostasis. Related proteins such as high-density lipoprotein (HDL) and very low-density lipoprotein (VLDL) work in tandem with LDL forming a complex system for managing lipid transport and affecting cholesterol levels.
LDL is closely associated with atherosclerosis and cardiovascular disease. High LDL levels lead to cholesterol accumulation in arterial walls promoting the formation of plaques and increasing the risk of heart disease. Apolipoprotein B-100 part of the LDL structure is often investigated in the context of these diseases because it mediates LDL's attachment to arterial walls. Understanding LDL's relationship with these disorders highlights the importance of controlling its levels through medical and lifestyle interventions therefore minimizing disease risk.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
Example flow cytometric analysis.
HepG2 cells were plated at 2 x 105 cells/well in a 24 well plate approximately 48 hours before addition of LDL-DyLightTM 488. After a four hour incubation with the LDL probe, cells were trypsinized, washed and stained with 7-AAD prior to flow cytometry. In this example analysis, after digital compensation, 7-AAD negative live cells are gated first, followed by scatter. Single cells are gated using an area versus height dot plot, and the geometric mean fluorescence intensity (MFI) of the resulting cells in the LDL-DyLightTM 488 channel is determined.
Lovastatin increases uptake of LDL.
HepG2 cells were plated at 2 x 105 cells/well in a 24 well plate and allowed to adhere overnight, before being treated with 1 μM Lovastatin or left untreated for 24 hours in MEM + 2% FBS. The final four hours of treatment included the probe LDL-DyLightTM 488. Cells were processed as described in the kit booklet and the flow cytometric data were analyzed as described in Figure 1. Average geometric mean fluorescence intestities (MFI) for each group are plotted.
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com